Roche gains FDA approval for HPV self-collection kit to enhance cervical cancer screening
Roche has achieved a significant milestone with the FDA approval of its innovative human papillomavirus (HPV) self-collection solution, positioning it as one of the first such tools available in the United States. This development promises to transform cervical cancer screening by making it more accessible and could play a crucial role in early detection and […]